← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	AGTC 51 DELISTED Applied Genetic Technologies Corporation AGTC	71	-11	-13%	$53.9M
52	52 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	71	+9	+15%	$279M
53	53 Abeona Therapeutics ABEO $273M	70	-5	-7%	$43.4M
54	GMDA 54 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	70	-3	-4%	$157M
55	55 Autolus Therapeutics AUTL $458M	69	+6	+10%	$170M
56	56 Adicet Bio ACET $47.7M	65	+12	+23%	$218M
57	57 Cabaletta Bio CABA $259M	63	-5	-7%	$135M
58	LOGC 58 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	63	+2	+3%	$69.9M
59	59 Instil Bio TIL $42.8M	62	+6	+11%	$1.35B
60	60 Pluri PLUR $12M	59	-1	-2%	$17.9M
61	61 DELISTED BRAINSTORM CELL THERAPUTC BCLI	57	-18	-24%	$21.4M
62	62 4D Molecular Therapeutics FDMT $693M	56	-8	-13%	$400M
63	SIOX 63 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	54	-2	-4%	$57.7M
64	64 Lyell Immunopharma LYEL $195M	52	+52	–	$1.29B
65	SGTX 65 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	52	0	0%	$209M
66	66 Immatics IMTX $1.09B	50	+6	+14%	$243M
67	67 Mesoblast MESO $1.81B	50	-2	-4%	$28.9M
68	SQZ 68 DELISTED SQZ Biotechnologies Company SQZ	49	+2	+4%	$196M
69	69 Taysha Gene Therapies TSHA $1.22B	49	+3	+7%	$389M
70	PTE 70 DELISTED PolarityTE, Inc. Common Stock PTE	48	-2	-4%	$11.1M
71	DBTX 71 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	46	-8	-15%	$168M
72	72 Senti Biosciences Holdings SNTI $7.62M	44	+44	–	$207M
73	73 INmune Bio INMB $44.4M	41	+8	+24%	$30.6M
74	74 Imunon IMNN $6M	37	-3	-8%	$11.5M
75	75 Lunai Bioworks LNAI $4.01M	37	-4	-10%	$13.3M